CEDAR KNOLLS, N.J., Nov. 9, 2012 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCQB:EMIS) (the "Company") announced today that management will host a conference call to discuss the Company's financial and operational results for the third quarter ended September 30, 2012 on Tuesday, November 13, 2012 at 10:00 AM ET. A press release will be issued prior to market open.
The live webcast of the conference call can be accessed through the company's web site at: www.emisphere.com. The live conference call dial-in number is: 1-877-303-9483 (United States and Canada) or 1-760-666-3584 (International). In addition, an archive of the webcast can be accessed through the same link and an audio replay of the call will be available beginning at 1:00 PM ET on November 13, 2012 through 11:59 PM ET on November 20, 2012 by calling 1-800-585-8367 (United States and Canada) or 1-404-537-3406 (International). The conference replay PIN is 70175224.
About Emisphere Technologies, Inc.
Emisphere is a biopharmaceutical company that focuses on a unique and improved delivery of pharmaceutical compounds, medical foods and dietary supplements using its Eligen® Technology. These molecules and compounds could be available currently or are under development. Such molecules are usually delivered by injection; in many cases, their benefits are limited due to poor bioavailability, slow on-set of action or variable absorption. The Eligen® Technology can be applied to the oral route of administration as well other delivery pathways, such as buccal, rectal, inhalation, intra-vaginal or transdermal. The company's website is: www.emisphere.com.
CONTACT: Alan L. Rubino, CEO 973.532.8000 or firstname.lastname@example.org Michael R. Garone, CFO 973.532.8005 or email@example.com